National and Kapodistrian University of Athens
Ποσοτικοποίηση του HIV-DNA σε μονοπύρηνα κύτταρα περιφερικού αίματος (PBMCs) φορέων της HIV λοίμωξης
Abstract
dc:descriptionThe rate of HIV-1 disease progression varies greatly among HIV-1-infected individuals, depending on several factors, such as baseline HIV RNA level, baseline CD4⁺ T-cell level, age at seroconversion, gender, etc. Quantification of HIV-RNA in plasma has routinely been used for assessment of the efficacy of HAART, and it provides a strong predictor of HIV-1 disease progression. The introduction of HAART in clinical practice increased the life expectancy and life quality of HIV-infected patients. Treatment with HAART allows a drastic reduction of the plasma HIV-RNA load, to such an extent that circulating HIV-1 in plasma becomes undetectable (<50 copies/ml) by the most sensitive viral detection assays. Given the drastic reduction of HIV-RNA level in plasma, a new prognostic marker was found, the levels of HIV-1 DNA in PBMCs, which can be used as a prognostic marker for HIV-1 infection. Moreover, in patients with undetectable HIV-RNA level, HIV-1 DNA consists the only marker of viral replication in PBMCs and lymphoid tissues. Several studies have demonstrated that HIV-1 DNA levels can be used as an independed prognostic marker in clinical practice for HIV-infected patients’ management, for disease progression, for optimizing therapy initiation, predicting treatment outcome and long-term success of HAART. The purpose of this study was to investigate the importance of HIV-1 DNA quantification in HIV-infected patients. For this purpose, we review all previously reported assays for HIV-1 DNA quantification as well all the studies investigating its role as an additional marker in HIV-infection and treatment initiation and outcome. Given the fact that there is not a commercially available assay for HIV-1 DNA, we develop an in house real-time PCR assay for HIV-1 DNA quantification in multiplex format with CCR5 reporter gene. The molecular beacon based multiplex real-time PCR assay was developed in LightCycler 2.0® apparatus. Thereafter the multiplex assay was performed in 115 randomly selected patients before HAART initiation, in order to find correlations of HIV-1 DNA baseline level with two other prognostic markers (HIV-RNA and CD4 T-cells count. Finally, a study protocol was set up in order to investigate whether HIV-1 DNA is a prognostic factor of the first line treatment.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2011
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Μπελούκας, Απόστολος
- Beloukas, Apostolos
Subjects
dc:subject × 12- DNA του ιού της ανθρώπινης ανοσοβιολογικής ανεπάρκειας
- Αλυσιδωτή αντίδραση πολυμεράσης πραγματικού χρόνου
- Προγνωστικοί δείκτες
- Εξέλιξη νόσου
- HIV-1 DNA
- Real-time PCR
- Prognostic markers
- Disease progression
- Ιατρική και Επιστήμες Υγείας
- Ιατρική Βιοτεχνολογία
- Medical and Health Sciences
- Medical Biotechnology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/31584